Effect of Melatonin on Cognitive Function and Sleep in relation to Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background.Sleep disturbances and cognitive dysfunction are common in patients with breast cancer. Disturbed sleep leads to poor cognitive performance and exogenous melatonin may improve sleep and attenuate cognitive dysfunction. We hypothesized that melatonin would improve sleep and cognitive function after surgery.Methods.This study reports secondary endpoints from a randomized, double-blind, placebo-controlled trial. Women, 30–75 years, were randomized to 6mg oral melatonin/placebo for 3 months. We assessed postoperative cognitive dysfunction (POCD) with a neuropsychological test battery, sleep with a diary, and sleep quality with VAS.Results. 54 patients were randomized to melatonin (n=28) or placebo (n=26); 11 withdrew (10 placebo, 1 melatonin,P=0.002). The incidence of POCD was 0% (0/20) [95% CI 0.0%; 16.8%] in the placebo group and 0% (0/26) [95% CI 0.0%; 13.2%] in the melatonin group 2 weeks postoperatively (P=1.00) and 6.3% (1/16) [95% CI 0.0%; 30.2%] in the placebo group and 0% (0/26) [95% CI 0.0%; 13.2%] in the melatonin group 12 weeks postoperatively (P=0.38). Sleep efficiency was significantly greater in the melatonin group; mean difference was 4.28% [95% CI 0.57; 7.82] (P=0.02). The total sleep period was significantly longer in the melatonin group; mean difference was 37.0 min [95% CI 3.6; 69.7] (P=0.03).Conclusion.Melatonin increased sleep efficiency and total sleep time but did not affect cognitive function. The dropout rate was significantly lower in the melatonin group. This trial is registered with Clinicaltrials.gov NCT01355523.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00583 · Cited by 7,363
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Subjective and objective sleepiness in the active individual
Åkerstedt, T., & Gillberg, M. (1990) · International Journal of Neuroscience · doi:10.3109/00207459008994241 · Cited by 3,088 · cited 1×
“The KSS measures the subjective level of sleepiness and is a 9-point scale ranging from 1 (extremely alert) to 9 (extremely sleepy – fighting sleep), where a score of 7 (sleepy – but no difficulty remaining awake) or more reflects EEG (electroencephalogram) and EOG (electrooculogram) verified changes with increased le…”
BackgroundBaglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.01.011 · Cited by 2,779
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
Ancoli-Israel, S., Cole, R., Alessi, C., Chambers, M., Moorcroft, W., & Pollak, C. P. (2003) · Sleep · doi:10.1093/sleep/26.3.342 · Cited by 2,751
The consensus sleep diary: standardizing prospective sleep self-monitoring
Carney, C. E., Buysse, D. J., Ancoli-Israel, S., Edinger, J. D., Krystal, A. D., Lichstein, K. L., & Morin, C. M. (2012) · Sleep · doi:10.5665/sleep.1642 · Cited by 2,172 · cited 2×
“SLEEP DIARY The sleep diary is regarded as the gold standard for subjective sleep assessment, although lack of a standardized and widely used sleep diary has compromised the ability to fully interpret and integrate results from previous studies [117].”
MethodNeurocognitive consequences of sleep deprivation
Goel, N., Rao, H., Durmer, J., & Dinges, D. (2009) · Seminars in Neurology · doi:10.1055/s-0029-1237117 · Cited by 2,154 · cited 1×
“It is well known that overall sleep loss and sleep fragmentation may have negative cognitive consequences [12, 13] and it has previously been shown that sleep disturbances may arise in the postoperative period after surgery for breast cancer [14] and persist for months or even years [1].”
BackgroundIndustry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Brzezinski, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360306 · Cited by 1,549
Neurocognitive Consequences of Sleep Deprivation
Durmer, J. S., & Dinges, D. F. (2005) · Seminars in Neurology · doi:10.1055/s-2005-867080 · Cited by 1,473
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 1×
“Targeting prevention of the depressive symptoms rather than treatment once the symptoms arise is another option which is well-known in other populations, as antidepressants have shown to be able to prevent poststroke depression [159] and interferon-α-induced depression in patients with malignant melanoma [160] and hep…”
BackgroundPlacebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109 · cited 1×
“On the contrary, an even larger effect of melatonin might be present as a placebo effect is most likely in a study like this [130, 131].”
BackgroundDepression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083 · cited 2×
“The consequences of these symptoms are an adverse effect on quality of life [17], reduced compliance to treatment [23, 24], lower patient satisfaction [25], and higher morbidity and mortality [18, 26-28].”
BackgroundMammalian circadian biology: elucidating genome-wide levels of temporal organization
Lowrey, P. L., & Takahashi, J. S. (2004) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.5.061903.175925 · Cited by 976
Bech, P., Rasmussen, N.-A., Olsen, L. R., Noerholm, V., & Abildgaard, W. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00309-8 · Cited by 975 · cited 6×
“A visit was scheduled 2 weeks postoperativelywhere patientswere testedwith the neuropsychological test battery and the MDI (data not reported here).”
MethodInfluentialDepression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972 · cited 2×
“The consequences of these symptoms are an adverse effect on quality of life [17], reduced compliance to treatment [23, 24], lower patient satisfaction [25], and higher morbidity and mortality [18, 26-28].”
BackgroundDirection and impact of language bias in meta-analyses of controlled trials: empirical study
Jüni, P., Holenstein, F., Sterne, J., Bartlett, C., & Egger, M. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.115 · Cited by 892
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Insomnia in the Context of Cancer: A Review of a Neglected Problem
Savard, J., & Morin, C. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.895 · Cited by 861
Shift work and vascular events: systematic review and meta-analysis
Vyas, M. V., Garg, A. X., Iansavichus, A. V., Costella, J., Donner, A., Laugsand, L. E., Janszky, I., Mrkobrada, M., Parraga, G., & Hackam, D. G. (2012) · BMJ · doi:10.1136/bmj.e4800 · Cited by 840 · cited 1×
“shift work that involves circadian disruption has recently been classified as “probably carcinogenic to humans” [11], shift work is associated with an increased risk of vascular events [12], sleep deprivation and sleep fragmentation lead to a variable negative impact on cognitive performance [7], and insomnia is assoc…”
BackgroundAls-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep
Cajochen, C., Kräuchi, K., & Wirz‐Justice, A. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00989.x · Cited by 735 · cited 1×
“In addition, several of melatonin’s proposed effects on promoting sleep and synchronizing circadian rhythm [91, 92, 102], and also melatonin’s antidepressant [76-83], anxiolytic [64-66], analgesic [65, 67-69], anti-inflammatory [72], and beneficial cognitive effects [84-86], could have both direct and indirect effects…”
BackgroundRajaratnam, S. M., & Arendt, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06108-6 · Cited by 711
Influence of psychological response on survival in breast cancer: a population-based cohort study
Watson, M., Haviland, J., Greer, S., Davidson, J., & Bliss, J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11392-2 · Cited by 705
Sleep disturbance in cancer patients
Davidson, J. R., MacLean, A. W., Brundage, M. D., & Schulze, K. (2002) · Social Science & Medicine · doi:10.1016/s0277-9536(01)00043-0 · Cited by 661
Circadian rhythm disturbances in depression
Germain, A., & Kupfer, D. J. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.964 · Cited by 644 · cited 1×
“Furthermore, disturbances in the circadian rhythm of patients with breast cancer are prevalent [99, 100], as they also are in patients with depression, alongside changes in melatonin secretion [58, 59, 101].”
BackgroundArendt, J., & Skene, D. J. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.05.002 · Cited by 629 · cited 2×
“05-10 mg orally [91, 92].”
BackgroundMajor depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Effects of exogenous melatonin on sleep: a meta-analysis
Brzezinski, A., Vangel, M. G., Wurtman, R. J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.06.004 · Cited by 541 · cited 2×
“The well-known effects of melatonin on sleep with an increased sleep efficiency and total sleep duration measured by polysomnography or actigraphy [15] were confirmed by our study.”
BackgroundPER3 polymorphism predicts sleep structure and waking performance
Viola, A. U., Archer, S. N., James, L. M., Groeger, J. A., Lo, J. C. Y., Skene, D. J., von Schantz, M., & Dijk, D.-J. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.073 · Cited by 520 · cited 1×
“With regard to the PER3 genotypes, several studies have investigated the phenotype of behavioral and cognitive response to sleep loss and changes in circadian phase [50-52].”
BackgroundPrevalence, Clinical Characteristics, and Risk Factors for Insomnia in the Context of Breast Cancer
Savard, J., Simard, S., Blanchet, J., Ivers, H., & Morin, C. M. (2001) · SLEEP · doi:10.1093/sleep/24.5.583 · Cited by 414 · cited 2×
“It is well known that overall sleep loss and sleep fragmentation may have negative cognitive consequences [12, 13] and it has previously been shown that sleep disturbances may arise in the postoperative period after surgery for breast cancer [14] and persist for months or even years [1].”
BackgroundDepression and degree of acceptance of adjuvant cytotoxic drugs
Colleoni, M., Mandala, M., Peruzzotti, G., Robertson, C., Bredart, A., & Goldhirsch, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02821-x · Cited by 351
Novel melatonin-based therapies: potential advances in the treatment of major depression
Hickie, I. B., & Rogers, N. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60095-0 · Cited by 334 · cited 1×
“Regarding clinical studies, agomelatin, a novel drug that works on melatonergic (MT1 and MT2), 5-HT2B and 5HT2C receptors has proven effective as an antidepressant with less side-effects than selective serotonin reuptake inhibitors (SSRIs) but with no difference in efficacy compared to other available antidepressants…”
BackgroundMorrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L. R., Flynn, P. J., Hynes, H. E., Banerjee, T. K., Kirshner, J. J., & King, D. K. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.070 · Cited by 324 · cited 2×
“Three other RCTs have been conducted in a mix of cancer patients investigating the effects of sertraline, paroxetine, fluoxetine against placebo on depression [169-171].”
BackgroundEfficacy and safety of mianserin in the treatment of depression of women with cancer
Costa, D., Mogos, I., & Toma, T. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb08081.x · Cited by 202 · cited 1×
“Interestingly, a high rate of dropouts, ranging up to as high as 55%, is a problem in many of the studies; two of the main reasons being a lack of effect or adverse effects [154-158].”
BackgroundA Randomized Study of How Physicians Interpret Research Funding Disclosures
Kesselheim, A. S., Robertson, C. T., Myers, J. A., Rose, S. L., Gillet, V., Ross, K. M., Glynn, R. J., Joffe, S., & Avorn, J. (2012) · New England Journal of Medicine · doi:10.1056/nejmsa1202397 · Cited by 183 · cited 1×
“METHODOLOGICAL CONSIDERATIONS Industry sponsorship and research funding can influence doctors in the decision-making process and create an industry bias that cannot be explained by the standard risk of bias assessment [180, 181].”
BackgroundPossible therapeutic value of melatonin in mild cognitive impairment: A retrospective study
Furio, A. M., Brusco, L. I., & Cardinali, D. P. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00491.x · Cited by 167
Prolonged melatonin administration decreases nocturnal blood pressure in women
CAGNACCI, A., CANNOLETTA, M., RENZI, A., BALDASSARI, F., ARANGINO, S., & VOLPE, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.008 · Cited by 156 · cited 1×
“Moreover, in a variety of experimental and clinical studies it has also been found to have sedative [64], anxiolytic [64-66], analgesic [65, 67-69], antihypertensive [70, 71], anti-inflammatory [72], oncostatic [7375], antioxidant [72], antidepressant [76-83] and beneficial cognitive effects [84-86].”
BackgroundAlshurafa, M., Briel, M., Akl, E. A., Haines, T., Moayyedi, P., Gentles, S. J., Rios, L., Tran, C., Bhatnagar, N., Lamontagne, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049163 · Cited by 126 · cited 1×
“To underline our main result and as an extra strength, we chose to perform worst and best case scenario analyses [135] where missing data were filled out with “YES” or “NO” for depression and both were significantly in favor of melatonin.”
MethodRegistering systematic reviews
Straus, S., & Moher, D. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.081849 · Cited by 108
Evolution of a Length Polymorphism in the Human PER3 Gene, a Component of the Circadian System
Nadkarni, N. A., Weale, M. E., von Schantz, M., & Thomas, M. G. (2005) · Journal of Biological Rhythms · doi:10.1177/0748730405281332 · Cited by 76 · cited 1×
“In most populations approximately 10% of individuals are homozygous for the 5-repeat (PER3), 50% are homozygous for the 4-repeat (PER3) and 40% are heterozygous (PER3) [46, 47].”
BackgroundMelatonin improves memory acquisition under stress independent of stress hormone release
Rimmele, U., Spillmann, M., Bärtschi, C., Wolf, O. T., Weber, C. S., Ehlert, U., & Wirtz, P. H. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1344-z · Cited by 46
Cited by
Safavynia, S. A., & Goldstein, P. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00752 · Cited by 339
Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline
Grassi, L., Zachariae, R., Caruso, R., Palagini, L., Campos-Ródenas, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.102047 · Cited by 96
Zahid, J. A., Grummedal, O., Madsen, M. T., & Gögenur, I. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.10.009 · Cited by 48
Self-citationNissen, E. R., Neumann, H., Knutzen, S. M., Henriksen, E. N., Amidi, A., Johansen, C., von Heymann, A., Christiansen, P., & Zachariae, R. (2024) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkae041 · Cited by 46
Metadata
- Authors
- Hansen, M. V., Madsen, M. T., Andersen, L. T., Hageman, I., Rasmussen, L. S., Bokmand, S., Rosenberg, J., & Gögenur, I.
- Venue
- International Journal of Breast Cancer
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-9
- ISSN
- 2090-3170 (ISSN-L)
- 2090-3189
- OpenAlex
- W2160756554
- Cited by
- 60
- References
- 42
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.